Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
Brano Therapeutics is a biotech developing therapies for cardio-metabolic and heart failure diseases.
Tetris Therapeutics is a platform-based biotechnology company
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
DiaMonTech is developing a medical device for non-invasive measurement of blood sugar values.
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.
Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Pathware is creating hardware and software to simplify digital pathology workflows.
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.
Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.
Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.
Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.
Heranova is developing innovative diagnostics and treatments designed to improve women's health and address reproductive challenges
Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.
Myrobalan Therapeutics is a biotechnology company developing oral neurorestorative therapies for individuals with CNS diseases.
Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.
Sonomotion is a medical device manufacturing company that specializes in providing medical solutions for kidney stones disease.
Clinical stage, novel technologies for managing Glaucoma
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
BioVenture has invested in 273 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 27 different industry categories.
Among tracked funding rounds, Arnatar Therapeutics received $52.0M in a Series A round. BioVenture's total known invested capital is $1.3B.
BioVenture's average investment size is $25.0M across its portfolio of 273 companies.
Recent BioVenture portfolio additions include Infinity Bio, Hillhurst Biopharmaceuticals, Brano Therapeutics, Axcynsis Therapeutics, Engimmune Therapeutics. These companies were founded in 2020 or later.